Literature DB >> 7931158

Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6.

L Foà-Tomasi1, E Avitabile, L Ke, G Campadelli-Fiume.   

Abstract

Hyperimmune rabbit and mouse sera raised to human herpesvirus 7 (HHV-7)-infected cells and an immune human serum identified 20[35S]methionine-[35S]cysteine-labelled proteins specific for HHV-7-infected cord blood mononuclear cells, ranging in apparent M(r) from 136K to 30K. The major proteins had apparent M(r) values of 121K, 100K, 87K, 85K, 60K, 51K, 46K, 42K, 40K and 36K. The human serum also identified seven [3H]glucosamine-labelled glycoproteins, with apparent M(r) values of 100K, 89K, 82K, 67K, 63K, 53K and 41K. Four monoclonal antibodies (MAbs) specific for HHV-7-infected cells were derived. Two reacted with a family of five antigenically related polypeptides (87K, 85K, 70K, 61K and 57K in apparent M(r)), designated as the p85 complex. Two reacted with 121K and 51K M(r) proteins designated as p121 and p51, respectively. Human sera react with high frequency with the p85 complex and to a lesser extent with p121; hence these two proteins appear to be immunodominant for both humans and laboratory animals. The hyperimmune mouse serum and some of the MAbs showed some cross-reactivity with HHV-6A(U1102)- and 6B(Z29)-infected cells. The implications of cross-reactivity with respect to the human immune response to HHV-6 and -7 infections and prevalence analyses are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931158     DOI: 10.1099/0022-1317-75-10-2719

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles.

Authors:  A Stefan; P Secchiero; T Baechi; W Kempf; G Campadelli-Fiume
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.

Authors:  W Kempf; V Adams; N Wey; R Moos; M Schmid; E Avitabile; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7.

Authors:  D Skrincosky; P Hocknell; L Whetter; P Secchiero; B Chandran; S Dewhurst
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Evaluation of immunoassays for detection of antibodies to human herpesvirus 7.

Authors:  J B Black; T F Schwarz; J L Patton; K Kite-Powell; P E Pellett; S Wiersbitzky; R Bruns; C Müller; G Jäger; J A Stewart
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

6.  Development of recombinant diagnostic reagents based on pp85(U14) and p86(U11) proteins to detect the human immune response to human herpesvirus 7 infection.

Authors:  A Stefan; M De Lillo; G Frascaroli; P Secchiero; F Neipel; G Campadelli-Fiume
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7.

Authors:  Michael Franti; Jean-Thierry Aubin; Guillemette De Saint-Maur; Haruhiko Kosuge; Koichi Yamanishi; Agnes Gautheret-Dejean; Antoine Garbarg-Chenon; Jean-Marie Huraux; Henri Agut
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

8.  Human Herpes Virus 7-related encephalopathy in children.

Authors:  Thomas Foiadelli; Virginia Rossi; Stefania Paolucci; Francesca Rovida; Federica Novazzi; Alessandro Orsini; Ilaria Brambilla; Gian Luigi Marseglia; Fausto Baldanti; Salvatore Savasta
Journal:  Acta Biomed       Date:  2022-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.